Navigation Links
Loyola receives NIH grant to study vitamin D deficiency in African populations

MAYWOOD, Ill. Researchers at Loyola University Chicago Stritch School of Medicine have received a five-year, $2.8 million grant from the National Institutes of Health to study vitamin D deficiency in people of African descent.

Researchers will evaluate the relation between low vitamin D levels and risks for certain chronic diseases, including osteoporosis and heart disease.

Evidence from numerous previous studies is "inconclusive and needs to be studied further," said Ramon Durazo, PhD, principal investigator and assistant professor in the Department of Preventive Medicine and Epidemiology. "This grant will allow us to take a more in-depth look at the role this nutrient plays in a specific group of people who are at risk for these conditions."

The study will include about 2,500 people, ages 25-45, from Ghana, South Africa, Seychelles, Jamaica and metropolitan Chicago. Researchers will determine whether lower vitamin D levels in African and African-descent populations compared with whites should be considered abnormal, or whether this disparity represents an ethnic-specific trait. The study also will evaluate whether vitamin D deficiency is related to bone density and factors that contribute to heart disease, including obesity, high blood pressure and blood sugar levels.

In the United States, African-Americans have been reported to have much lower vitamin D levels. "This is currently thought to be due to their darker skin color, which impairs the ability to utilize the sun for the production of the nutrient," said Pauline Camacho, MD, director of Loyola University Health System's Osteoporosis and Metabolic Bone Disease Center. "Also, this group often has a higher body mass index. This could play a role in the deficiency, as vitamin D is a fat-soluble vitamin."

Only about 3 percent of African-Americans have optimal levels of vitamin D. Some researchers believe low levels may contribute to obesity, high blood pressure and cardiovascular disease.

Sampling African-origin populations across a range of latitudes, calcium intakes, diet patterns and lifestyles will enable researchers to help define the optimal level of vitamin D in the multi-ethnic U.S. population.

Contact: Jim Ritter
Loyola University Health System

Related biology news :

1. Wistar Institute researcher receives New Innovator award from NIH
2. L-1 Identity Solutions Receives $5.9 Million Drivers License Contract Expansion from the State of Mississippi
3. Kount Receives Patent for Device Fingerprinting
4. American College of Medical Genetics receives $13.5M NIH contract
5. Penn State receives new NASA astrobiology grant
6. Global Viral Forecasting Initiative receives $11M to implement pandemic early warning system
7. Vidaza receives positve opinion from European CHMP
8. Case Western Reserve receives Ellison Medical Foundation New Scholar in Aging award
9. Montana State partnership receives $66.9M for carbon sequestration
10. Oklahoma EPSCoR receives $20 million for biofuels research
11. UC Riverside rice geneticist receives high honor from US Department of Agriculture
Post Your Comments:
(Date:10/29/2015)... Oct. 29, 2015  The J. Craig Venter Institute ... "DNA Synthesis and Biosecurity: Lessons Learned and Options for ... Health and Human Services guidance for synthetic biology providers ... --> --> Synthetic ... the potential to pose unique biosecurity threats. It now ...
(Date:10/29/2015)... Connecticut , October 29, 2015 ... a biometric authentication company focused on the growing ... smart wallet announces that StackCommerce, a leading marketplace ... be featuring the Wocket® smart wallet on StackSocial ... NXTD ) ("NXT-ID" or the "Company"), a biometric ...
(Date:10/27/2015)... JOSE, Calif. , Oct. 27, 2015 Synaptics ... interface solutions, today announced that Google has adopted the ... of touch controller solutions to power its newest flagship ... 6P by Huawei. --> ... partners like Google to provide strategic collaboration in the ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS; TSX: AEZ) ... remain fundamentally strong and highlights the following developments: ... DSMB recommendation to continue the ZoptEC Phase 3 ... final interim efficacy and safety data , ... with heavily pretreated castration- and Taxane-resistant prostate cancer ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... ... company uBiome, were featured on AngelList early in their initial angel funding process. ... AngelList syndicate for individuals looking to make early stage investments in the microbiome ...
(Date:11/24/2015)... 24, 2015 Halozyme Therapeutics, Inc. (NASDAQ: HALO ) ... New York on Wednesday, December 2 at 9:30 ... president and CEO, will provide a corporate overview. th ... at 1:00 p.m. ET/10:00 a.m. PT . Jim ... provide a corporate overview. --> th Annual Oppenheimer ...
(Date:11/24/2015)... , Nov. 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. ... IIROC on behalf of the Toronto Stock Exchange, confirms ... there are no corporate developments that would cause the ... --> --> About Aeterna Zentaris ... . --> Aeterna Zentaris is a specialty ...
Breaking Biology Technology: